Suchergebnisse - "Sebastian, Shaji"

PubPharm (4)

1

Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic

enthalten in: Gut | 2023

von Kennedy, N. | Janjua, M. | Chanchlani, N. | +20

2

The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients

enthalten in: EBioMedicine | 2023

von Alexander, J. | Mullish, B. | Danckert, N. | +24

3

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

enthalten in: Nature communications | 2022

von Lin, S. | Kennedy, N. | Saifuddin, A. | +130

4

Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD

enthalten in: Gut | 2021

von Kennedy, N. | Lin, S. | Goodhand, J. | +24

CommentIn: Gastroenterology. 2021 Dec;161(6):2057-2059. - PMID 34529994

1
[1]